134 related articles for article (PubMed ID: 23886447)
1. New issues for copper-64: from precursor to innovative PET tracers in clinical oncology.
Evangelista L; Luigi M; Cascini GL
Curr Radiopharm; 2013 Sep; 6(3):117-23. PubMed ID: 23886447
[TBL] [Abstract][Full Text] [Related]
2. Intrinsically copper-64-labeled organic nanoparticles as radiotracers.
Liu TW; MacDonald TD; Shi J; Wilson BC; Zheng G
Angew Chem Int Ed Engl; 2012 Dec; 51(52):13128-31. PubMed ID: 23154923
[TBL] [Abstract][Full Text] [Related]
3. Radiopharmaceuticals Labelled with Copper Radionuclides: Clinical Results in Human Beings.
Follacchio GA; De Feo MS; De Vincentis G; Monteleone F; Liberatore M
Curr Radiopharm; 2018; 11(1):22-33. PubMed ID: 29231149
[TBL] [Abstract][Full Text] [Related]
4. Copper-64 based radiopharmaceuticals for brain tumors and hypoxia imaging.
Pasquali M; Martini P; Shahi A; Jalilian AR; Osso JA; Boschi A
Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):371-381. PubMed ID: 33026209
[TBL] [Abstract][Full Text] [Related]
5. Detection of increased 64Cu uptake by human copper transporter 1 gene overexpression using PET with 64CuCl2 in human breast cancer xenograft model.
Kim KI; Jang SJ; Park JH; Lee YJ; Lee TS; Woo KS; Park H; Choe JG; An GI; Kang JH
J Nucl Med; 2014 Oct; 55(10):1692-8. PubMed ID: 25091475
[TBL] [Abstract][Full Text] [Related]
6. High tumor uptake of (64)Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers.
Jørgensen JT; Persson M; Madsen J; Kjær A
Nucl Med Biol; 2013 Apr; 40(3):345-50. PubMed ID: 23394821
[TBL] [Abstract][Full Text] [Related]
7. Establishing Reliable Cu-64 Production Process: From Target Plating to Molecular Specific Tumor Micro-PET Imaging.
Xie Q; Zhu H; Wang F; Meng X; Ren Q; Xia C; Yang Z
Molecules; 2017 Apr; 22(4):. PubMed ID: 28420176
[TBL] [Abstract][Full Text] [Related]
8. Urokinase injection-triggered clearance enhancement of a 4-arm PEG-conjugated
Matsumura K; Zouda M; Wada Y; Yamashita F; Hashida M; Watanabe Y; Mukai H
Int J Pharm; 2018 Jul; 545(1-2):206-214. PubMed ID: 29746998
[TBL] [Abstract][Full Text] [Related]
9. Exploring pitfalls of
Striese F; Sihver W; Gao F; Bergmann R; Walther M; Pietzsch J; Steinbach J; Pietzsch HJ
Amino Acids; 2018 Oct; 50(10):1415-1431. PubMed ID: 30039310
[TBL] [Abstract][Full Text] [Related]
10. Copper-64 radiopharmaceuticals for PET imaging of cancer: advances in preclinical and clinical research.
Anderson CJ; Ferdani R
Cancer Biother Radiopharm; 2009 Aug; 24(4):379-93. PubMed ID: 19694573
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and comparative evaluation of novel (64)Cu-labeled high affinity cell-specific peptides for positron emission tomography imaging of tumor vasculature.
Merrill JR; Krajewski K; Yuan H; Frank JE; Lalush DS; Patterson C; Veleva AN
Biomaterials; 2016 Apr; 84():241-249. PubMed ID: 26839954
[TBL] [Abstract][Full Text] [Related]
12. Bis(thiosemicarbazonato) Cu-64 complexes for positron emission tomography imaging of Alzheimer's disease.
Fodero-Tavoletti MT; Villemagne VL; Paterson BM; White AR; Li QX; Camakaris J; O'Keefe G; Cappai R; Barnham KJ; Donnelly PS
J Alzheimers Dis; 2010; 20(1):49-55. PubMed ID: 20164590
[TBL] [Abstract][Full Text] [Related]
13. Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer.
Liu Z; Li ZB; Cao Q; Liu S; Wang F; Chen X
J Nucl Med; 2009 Jul; 50(7):1168-77. PubMed ID: 19525469
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [
Mansour N; Paquette M; Ait-Mohand S; Dumulon-Perreault V; Guérin B
Nucl Med Biol; 2018 Jan; 56():31-38. PubMed ID: 29154145
[TBL] [Abstract][Full Text] [Related]
15. The development of copper radiopharmaceuticals for imaging and therapy.
Shokeen M; Wadas TJ
Med Chem; 2011 Sep; 7(5):413-29. PubMed ID: 21711219
[TBL] [Abstract][Full Text] [Related]
16. Copper chelation chemistry and its role in copper radiopharmaceuticals.
Wadas TJ; Wong EH; Weisman GR; Anderson CJ
Curr Pharm Des; 2007; 13(1):3-16. PubMed ID: 17266585
[TBL] [Abstract][Full Text] [Related]
17. Imaging of Prostate Cancer Using
Singh A; Kulkarni HR; Baum RP
PET Clin; 2017 Apr; 12(2):193-203. PubMed ID: 28267453
[TBL] [Abstract][Full Text] [Related]
18. Photoactivatable bis(thiosemicarbazone) derivatives for copper-64 radiotracer synthesis.
Earley DF; Esteban Flores J; Guillou A; Holland JP
Dalton Trans; 2022 Mar; 51(13):5041-5052. PubMed ID: 35285835
[TBL] [Abstract][Full Text] [Related]
19. Copper-64 labeled nanoparticles for positron emission tomography imaging: a review of the recent literature.
Capriotti G; Varani M; Lauri C; Franchi G; Pizzichini P; Signore A
Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):346-355. PubMed ID: 33073558
[TBL] [Abstract][Full Text] [Related]
20. Recent Advances in
Krasnovskaya OO; Abramchuck D; Erofeev A; Gorelkin P; Kuznetsov A; Shemukhin A; Beloglazkina EK
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
